Patterns of Dose Escalation Amongst Patients with Ulcerative Colitis and Crohn's Disease Treated with Vedolizumab vs. Infliximab in the United States

被引：0
|
作者：
Khalid, Javaria Mona [1 ]
Raluy-Callado, Mireia [2 ]
Li, Qian [3 ]
Luo, Michelle [4 ]
Lasch, Karen [4 ]
机构：
[1] Takeda Dev Ctr Europe Ltd, London, England
[2] Evidera, London, England
[3] Evidera, Lexington, MA USA
[4] Takeda Pharmaceut USA Inc, Deerfield, IL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2016年 / 111卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
700
引用
收藏
页码：S316 / S317
页数：2
相关论文
共 50 条
  • [31] Vedolizumab Dose Escalation Improves Therapeutic Response in a Subset of Patients with Ulcerative Colitis
    Courtney Perry
    Kyle Fischer
    Ahmed Elmoursi
    Cody Kern
    Alden Currier
    Praneeth Kudaravalli
    Olalekan Akanbi
    Nishant Tripathi
    Pradeep Yarra
    Leon Su
    Deborah Flomenhoft
    Arnold Stromberg
    Terrence A. Barrett
    Digestive Diseases and Sciences, 2021, 66 : 2051 - 2058
  • [32] Investigating fatigue in vedolizumab-treated patients with ulcerative colitis or Crohn's disease from a Belgian registry
    Louis, E.
    Muls, V.
    Bossuyt, P.
    Colard, A.
    Nakad, A.
    Baert, D.
    Mana, F.
    Caenepeel, P.
    Vanden Branden, S.
    Vermeire, S.
    D'Heygere, F.
    Strubbe, B.
    Cremer, A.
    Setakhr, V.
    Baert, F.
    Vijverman, A.
    Coenegrachts, J. L.
    Flamme, F.
    Hantson, A.
    Bennett, D.
    Van Gassen, G.
    Hantsbarger, G.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S503 - S503
  • [33] Vedolizumab Dose Escalation Improves Therapeutic Response in a Subset of Patients with Ulcerative Colitis
    Perry, Courtney
    Fischer, Kyle
    Elmoursi, Ahmed
    Kern, Cody
    Currier, Alden
    Kudaravalli, Praneeth
    Akanbi, Olalekan
    Tripathi, Nishant
    Yarra, Pradeep
    Su, Leon
    Flomenhoft, Deborah
    Stromberg, Arnold
    Barrett, Terrence A.
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (06) : 2051 - 2058
  • [34] Payer addressable burden of Crohn's disease in patients treated with ustekinumab and vedolizumab in the United States
    Ghosh, T.
    Smith, I.
    Fehr, J.
    Davidson, J.
    Fan, T.
    Candela, N.
    Tsang, C.
    Koch, T.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S461 - S462
  • [35] DISCONTINUATION OF CORTICOSTEROIDS AMONG CROHN'S DISEASE PATIENTS TREATED WITH VEDOLIZUMAB IN THE UNITED STATES (US)
    Patel, Haridarshan
    Chastek, Benjamin
    Null, Kyle D.
    Demuth, Dirk
    GASTROENTEROLOGY, 2017, 152 (05) : S397 - S397
  • [36] Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab
    Favale, Agnese
    Onali, Sara
    Caprioli, Flavio
    Pugliese, Daniela
    Armuzzi, Alessandro
    Macaluso, Fabio Salvatore
    Orlando, Ambrogio
    Viola, Anna
    Fries, Walter
    Rispo, Antonio
    Castiglione, Fabiana
    Mocci, Giammarco
    Chicco, Fabio
    Usai, Paolo
    Calabrese, Emma
    Biancone, Livia
    Monteleone, Giovanni
    Fantini, Massimo Claudio
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (11) : 1805 - 1812
  • [37] Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn's disease and ulcerative colitis included in randomised controlled trials
    Peyrin-Biroulet, Laurent
    Arkkila, Perttu
    Armuzzi, Alessandro
    Danese, Silvio
    Ferrante, Marc
    Guardiola, Jordi
    Jahnsen, Jorgen
    Louis, Edouard
    Lukas, Milan
    Reinisch, Walter
    Roblin, Xavier
    Smith, Philip J.
    Kwon, Taek
    Kim, Jeeyoung
    Yoon, Sangwook
    Kim, Dong-Hyeon
    Atreya, Raja
    BMC GASTROENTEROLOGY, 2024, 24 (01)
  • [38] Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn’s disease and ulcerative colitis included in randomised controlled trials
    Laurent Peyrin‐Biroulet
    Perttu Arkkila
    Alessandro Armuzzi
    Silvio Danese
    Marc Ferrante
    Jørgen Jordi Guardiola
    Edouard Jahnsen
    Milan Louis
    Walter Lukáš
    Xavier Reinisch
    Philip J Roblin
    Taek Smith
    Jeeyoung Kwon
    Sangwook Kim
    Dong-Hyeon Yoon
    Raja Kim
    BMC Gastroenterology, 24
  • [39] THE INFLUENCE OF INFLIXIMAB ON POSTOPERATIVE COMPLICATIONS IN PATIENTS WITH ULCERATIVE COLITIS AND CROHN'S DISEASE
    Ma, J.
    Trencheva, K.
    Sonoda, T.
    Shukla, P.
    Milsom, J.
    Lee, S.
    DISEASES OF THE COLON & RECTUM, 2011, 54 (05) : E105 - E105
  • [40] Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn's Disease Patients Stratified by Age
    Yajnik, Vijay
    Khan, Nabeel
    Dubinsky, Marla
    Axler, Jeffrey
    James, Alexandra
    Abhyankar, Brihad
    Lasch, Karen
    ADVANCES IN THERAPY, 2017, 34 (02) : 542 - 559
12345